Pharma & BioPharma Market

Vinit Saxena is the founder and CEO of Sepragen Corporation. He has developed and commercialized innovative technologies for fast and efficient Bio-purification and Cell Culture that are routinely used by leading biotechs in the commercial manufacture of over 24 FDA approved drugs. Also Co-developed the Sepralac process for isolating whey proteins and developed other pioneering technologies used for isolating high nutritional ingredients. Authored 12 patents. Sepragen Corporation is a proven technology leader with a recognizable and growing presence in its chosen fields.

Wan Tung has 12 years of working experience in analytical science, specializing in method development of various LC/LCMS applications. Her recent research work at Shimadzu has mainly focused on fully automated pre-column derivatization of amino acids in a variety of food and biopharmaceutical sample matrices. Prior to joining Shimadzu, Wan Tung started her professional career as a QA/QC chemist in a Pharmaceutical multinational company. She earned her Bachelor's (Honour's) degree in Chemistry back in 2009.